Clinical trial
Effects of the Administration of Albumin in Patients With Cirrhosis and Acute Hepatic Encephalopathy.
NCT00886925 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of the Administration of Albumin in Patients With Cirrhosis and Acute Hepatic Encephalopathy.
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- July 31, 2012
- Enrollment
- 56 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.